Uncooperative threat reduction | Egyptian H5N1 influenza viruses – cause for concern? | Time and money are being wasted in the lab | The primary mode of smallpox transmission: Implications for biodefense | Is the newly FDA approved influenza vaccine the game changer we need? | Select-agent status could slow development of anti-SARS therapies | UK government injects nearly $1 billion into research | DNA hydrogel remembers its original shape when resubmerged | Countries to examine options for strengthening bioweapons convention | 100 millionths person receives lifesaving meningitis vaccine | Early rise in US flu activity continues | Scientist’s technique dramatically reduces E. coli numbers | PREDICT program a model for global pandemic prevention

See what we’re reading this week at Global Biodefense on topics like bioweapons convention renewal, anti-SARS therapeutics, smallpox transmission and more…

Uncooperative threat reduction (Bulletin of the Atomic Scientists)

Egyptian H5N1 influenza viruses – cause for concern? (PLOS Pathogens)

Time and money are being wasted in the lab (Chronicle)

The primary mode of smallpox transmission – Implications for biodefense (Frontiers)

Is the newly approved influenza vaccine the game-changer we need? (UMN Healthtalk)

Select-agent status could slow development of anti-SARS therapies (Nature)

UK government injects nearly $1 billion into research (Science)

DNA hydrogel remembers its original shape when resubmerged (C&EN)

Countries to examine options for strengthening bioweapons convention (NTI GSN)

100 millionths person receives lifesaving meningitis vaccine (WHO)

Early rise in US flu activity continues (CIDRAP)

Scientist’s technique dramatically reduces E. coli numbers (Univ of Illinois)